Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05665543 · ClinicalTrials.gov registry record · NA
Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
A NA study of Cancer and HPV Associated Cancer, sponsored by Masonic Cancer Center, University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT05665543: Active NA study of Cancer and HPV Associated Cancer, sponsored by Masonic Cancer Center, University of Minnesota.
NCT05665543 is a NA study of Cancer and HPV Associated Cancer that is active but no longer recruiting, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 162 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05665543, a NA study of Cancer and HPV Associated Cancer, is active but no longer recruiting, sponsored by Masonic Cancer Center, University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of this study are to increase HPV vaccination initiation and 3-dose completion among pediatric, adolescent, and young adult (PAYA) cancer survivors
Primary Outcome
Number of participants who complete the 3-dose HPV vaccine series within 12 months of study enrollment.
Conditions Studied
Interventions
- BEHAVIORAL GLAm app
Study Locations (1)
Minnesota
- University of Minnesota Masonic Cancer Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT05665543 still lists
NCT05665543 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which GLAm app is the first listed.
NCT05665543 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05665543 about?
NCT05665543 is a clinical study titled "Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors". The primary objectives of this study are to increase HPV vaccination initiation and 3-dose completion among pediatric, adolescent, and young adult (PAYA) cancer survivors
What is the current status of trial NCT05665543?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2023-07-24. Estimated completion is 2026-08.
What conditions does trial NCT05665543 study?
This clinical trial studies the following conditions: Cancer, HPV Associated Cancer.
What interventions are being tested in trial NCT05665543?
The interventions under investigation include: GLAm app (BEHAVIORAL).
Who is sponsoring clinical trial NCT05665543?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05665543 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05665543's enrollment target sits among peer trials
162 260th of 615 higher than 355 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI